Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Physiological Effects of Exenatide on Heart Failure
2006-005220-16Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Apr 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of exenatide in heart failure (HF) and type 2 diabetes mellitus (T2DM), sponsored by Karolinska Institutet. Primary endpoint: Cardiac index response to exenatide. Started Apr 2007; status: completed.
02
Drugs
exenatide
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-005220-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005220-16.